Atorvastatin, Sildenafil [Design Issues]

posted by Paresh – 2011-03-31 09:30 (5569 d 13:32 ago) – Posting: # 6842
Views: 4,216

Hi,

If you want to submit the study in US FDA than pls. find study design below.
For [image]  sildenafil and for [image]  atorvastatin.

And if EMEA submission need to conduct 2 study For sildenafil 2 way cross over study under fasting condition in healthy males and for atorvastatin partial replicate study (Pls. proof the HVDs using literature or pilot study) under fasting conditions in heathy males and females.


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe]
Edit: Guidances linked. [Helmut]

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
340 visitors (0 registered, 340 guests [including 72 identified bots]).
Forum time: 23:03 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5